Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia
PubMed Similar studies Analyze with GEO2R
Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
PubMed Similar studies GEO Profiles Analyze DataSet
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array
Patient 452 treated 4 weeks
Patient 452 treated 4h
Patient 452 treated 24h
Patient 452 control
Patient 451 treated 4 weeks
Patient 451 treated 4h
Patient 451 treated 24h
Patient 451 control
Patient 450 treated 4 weeks
Patient 450 treated 4h
Patient 450 treated 24h
Patient 450 control
Patient 449 treated 4 weeks
Patient 449 treated 4h
Patient 449 treated 24h
Patient 449 control
Patient 448 treated 4h
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on